LC-MI-3 is an orally active and potent PROTAC degrader of interleukin-1 receptor-associated kinase 4 (IRAK4), with a DC50 value of 47.3 nM. It effectively inhibits the activation of downstream NF-kappaB signaling. LC-MI-3 is applicable for research in both acute and chronic inflammatory skin conditions.
Formel:
C39H36N8O8
Target-Kategorie:
PROTACs|||IRAK|||NF-kappaB
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
